SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-18-028122
Filing Date
2018-11-07
Accepted
2018-11-07 17:13:43
Documents
5
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A drna-10qa_20180930.htm 10-Q/A 1757420
2 EX-31.1 drna-ex311_8.htm EX-31.1 8059
3 EX-31.2 drna-ex312_6.htm EX-31.2 8055
4 EX-32.1 drna-ex321_7.htm EX-32.1 7432
5 GRAPHIC ganldet0kv42000001.jpg GRAPHIC 36274
  Complete submission text file 0001564590-18-028122.txt   1832054
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36281 | Film No.: 181167330
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1